We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAN:NYSEManpowerGroup Analysis

Data as of 2026-05-19 - not real-time

$27.68

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

ManpowerGroup (MAN) is trading at $27.68, comfortably below its 20‑day SMA of 29.32 and 50‑day SMA of 28.71, indicating short‑term weakness. The RSI sits at 44.3, just under the neutral 50 level, while the MACD histogram remains negative, confirming a bearish momentum bias. With a 30‑day volatility of 57 % and a beta of 0.76, price swings are pronounced yet less correlated with the broader market. The current price is above the computed support of $25.19 but well under the resistance near $33.06, framing a potential upside corridor. Market sentiment is extremely greedy (Fear‑Greed Index 88.8), which may be inflating short‑term buying pressure. Recent news announced a semi‑annual dividend of $0.72 per share, sustaining the attractive 5.2 % yield but raising sustainability questions.
Fundamentally, MAN trades at a forward P/E of 5.78 versus an industry average of 29.5, and its price‑to‑book of 0.62 signals deep discounting. However, trailing earnings are negative (EPS –$0.36) and free cash flow is –$46.7 M, while the payout ratio exceeds 130 %, suggesting the dividend may be strained. The consensus target price of roughly $30.3 implies about a 9.6 % upside, aligning with the computed upside of 29.9 % but tempered by cash‑flow weakness. Debt stands at $1.54 B against $0.22 B of cash, yielding a debt‑to‑equity of ~75 %, which adds balance‑sheet pressure. Given the blend of cheap valuation and earnings volatility, the stock appears undervalued but carries medium‑to‑high risk. Investors should therefore monitor cash‑flow generation and dividend coverage before scaling positions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below short‑term SMAs
  • bearish MACD momentum
  • high dividend payout ratio with negative cash flow

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • forward P/E ~5.8 vs industry 29.5
  • target price ~30.3 suggests upside
  • attractive 5.2% dividend yield

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • global staffing demand growth
  • valuation remains cheap relative to book
  • ongoing cash‑flow and debt concerns

Key Metrics & Analysis

Financial Health

Revenue Growth10.30%
Profit Margin-0.09%
P/E Ratio5.8
ROE-0.79%
ROA2.33%
Debt/Equity74.50
P/B Ratio0.6
Op. Cash Flow$-77200000
Free Cash Flow$-46725000
Industry P/E29.5

Technical Analysis

TrendNeutral
RSI44.3
Support$25.19
Resistance$33.06
MA 20$29.32
MA 50$28.71
MA 200$32.27
MACDBearish
VolumeStable
Fear & Greed Index88.77

Valuation

Target Price$35.94
Upside/Downside29.86%
GradeUndervalued
TypeValue
Dividend Yield5.20%

Risk Assessment

Beta0.76
Volatility57.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.